(2S)-2-amino-3-(4-bromophenyl)propanamide | 500767-10-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-2-amino-3-(4-bromophenyl)propanamide
• CAS: 500767-10-2
• 化学式: C₉H₁₁BrN₂O
• 分子量: 243.103
• InChiKey: IMIDKBDZFMKIDQ-QMMMGPOBSA-N

物化性质

• 沸点：
  416.1±40.0 °C(Predicted)
• 密度：
  1.521±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  69.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2S)-2-amino-3-(4-bromophenyl)propanamide 在 盐酸 、 bis-triphenylphosphine-palladium(II) chloride 、 三氟甲磺酸 、 sodium carbonate 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 苯甲醚 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 乙醇 、 二氯甲烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 、 异丙醇 为溶剂， 反应 3.16h， 生成 Hydroxyethylamine-based inhibitor 16a
  参考文献：
  名称：

  Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human Erythrocytes

  摘要：

  A series of protease inhibitors targeted at the malarial enzymes plasmepsin I and II, and encompassing a basic hydroxyethylamine transition state isostere scaffold, was prepared. The substituents in the P1' position were varied and the biological activities expressed in K-i-values ranged from 60 to > 2000 nM. A more than 4-fold selectivity for either of the plasmepsins could be achieved. All of the active compounds exhibited high preference for the plasmepsins over cathepsin D, the most closely related human protease. A few active compounds were shown to inhibit parasite growth in cultured infected human erythrocytes. An ED50 value as low as 1.6 muM was observed for one of the inhibitors despite K-i values of 115 nM (Plm I) and 121 nM (Plm II).

  DOI：

  10.1021/jm020951i
• 作为产物：
  描述：

  L-对溴苯丙氨酸甲酯 在 氨 作用下， 以 甲醇 为溶剂， 以1.96 g的产率得到(2S)-2-amino-3-(4-bromophenyl)propanamide
  参考文献：
  名称：

  Design and Synthesis of Plasmepsin I and Plasmepsin II Inhibitors with Activity in Plasmodium falciparum-Infected Cultured Human Erythrocytes

  摘要：

  A series of protease inhibitors targeted at the malarial enzymes plasmepsin I and II, and encompassing a basic hydroxyethylamine transition state isostere scaffold, was prepared. The substituents in the P1' position were varied and the biological activities expressed in K-i-values ranged from 60 to > 2000 nM. A more than 4-fold selectivity for either of the plasmepsins could be achieved. All of the active compounds exhibited high preference for the plasmepsins over cathepsin D, the most closely related human protease. A few active compounds were shown to inhibit parasite growth in cultured infected human erythrocytes. An ED50 value as low as 1.6 muM was observed for one of the inhibitors despite K-i values of 115 nM (Plm I) and 121 nM (Plm II).

  DOI：

  10.1021/jm020951i

文献信息

• SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C
  申请人：GRUNDL Marc

  公开号：US20130172327A1

  公开（公告）日：2013-07-04

  Disclosed are N-1-cyano-2-(phenyl)ethyl)-2-azabicyclo[2.2.1]heptane-3-carboxamides of formula I and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of respiratory diseases.

  公开了式I的N-1-氰基-2-(苯基)乙基)-2-氮杂双环[2.2.1]庚烷-3-羧酰胺，以及它们作为Cathepsin C抑制剂的用途，含有它们的药物组合物，以及将它们用作治疗和/或预防呼吸道疾病的药剂的方法。
• [EN] SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTANE-3-CARBOXAMIDE INHIBITORS OF CATHEPSIN C<br/>[FR] N-[1-CYANO-2-(PHÉNYL)ÉTHYL]-2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXAMIDE SUBSTITUÉ UTILISÉ COMME INHIBITEUR DE LA CATHEPSINE C
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2013041497A1

  公开（公告）日：2013-03-28

  This invention relates to N-1-cyano-2-(phenyl)ethyl)-2-azabicyclo[2.2.1]heptane-3-carboxamides of formula I, and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of respiratory diseases.

  本发明涉及式I的N-1-氰基-2-(苯基)乙基)-2-氮杂双环[2.2.1]庚烷-3-羧酰胺，以及其作为Cathepsin C抑制剂的用途，含有这些化合物的药物组合物，以及将其用作治疗和/或预防呼吸道疾病的药物的方法。
• [EN] SUBSTITUTED 2-AZA-BICYCLO[2.2.2]OCTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C<br/>[FR] (BENZYL-CYANO-MÉTHYL)-AMIDES DE L'ACIDE 2-AZA-BICYCLO[2.2.2]OCTANE-3-CARBOXYLIQUE SUBSTITUÉS INHIBITEURS DE LA CATHEPSINE C
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2014140091A1

  公开（公告）日：2014-09-18

  This invention relates to 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. asthma and allergic diseases, gastrointestinal inflammatory diseases, eosinophilic diseases, chronic obstructive pulmonary disease, infection by pathogenic microbes, rheumatoid arthritis or atherosclerosis.

  本发明涉及式为1的2-Aza-bicyclo[2.2.2]octane-3-羧酸（苄基-氰基-甲基）-酰胺及其作为Cathepsin C抑制剂的用途，包含它们的制药组合物，以及将它们用作治疗和/或预防与二肽基肽酶I活性相关的疾病的药物，例如哮喘和过敏性疾病，胃肠道炎症性疾病，嗜酸性疾病，慢性阻塞性肺疾病，致病微生物感染，类风湿性关节炎或动脉粥样硬化疾病。
• [EN] CONDENSED HETEROCYCLIC SYSTEM DERIVATIVES, PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] DERIVES DE SYSTEMES HETEROCYCLIQUES CONDENSES, LEUR PREPARATION, LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
  申请人：AVENTIS PHARMA S.A.

  公开号：WO1999041248A1

  公开（公告）日：1999-08-19

  (EN) The invention concerns novel products of general formula (I), their preparation, pharmaceutical compositions containing them and the use thereof for preparing medicines. In general formula (I) R1 represents a -CO-CH(NH2)-CH2SH, or -CH2-CH(NH2)-CH2SH, or -CHRi1Ri2 radical; R2 represents a hydrogen atom, an alkyl, aralkyl, aryl, alkylcarbonyl, aralkylcarbonyl, heterocycloalkyl radical; R3 represents a hydrogen atom or a halogen atom or an alkyl, aryl, aralkyl radical; R4 represents a -CHRi3Ri4 radical; R5 represents a hydrogen atom, or a -C(O)-Ri5 radical; R6 represents a hydrogen atom or an alkyl, aryl, aralkyl radical; R7, R8 represent a hydrogen atom or an alkyl, aryl, aralkyl radical; X represents a hydrogen atom or a -S(O)1 radical.(FR) Nouveaux produits de formule générale (I), leur préparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la préparation de médicaments. Dans la formule générale (I), R1 représente un radical -CO-CH(NH2)-CH2SH, ou -CH2-CH(NH2)-CH2SH, ou -CHRi1Ri2; R2 représente un atome d'hydrogène, un radical alkyle, aralkyle, aryle, alkylcarbonyle, aralkylcarbonyle, arylcarbonyle, hétérocyclalkyle; R3 représente un atome d'hydrogène ou un atome d'halogène ou un radical alkyle, aryle, aralkyle; R4 représente un radical -CHRi3Ri4; R5 représente un atome d'hydrogène, ou un radical -C(O)-Ri5; R6 représente un atome d'hydrogène ou un radical alkyle, aryle, aralkyle; R7, R8 représentent un atome d'hydrogène ou un radical alkyle, aryle, aralkyle; X représente un atome d'oxygène ou un radical -S(O)1.

  本发明涉及一般式（I）的新型产品，其制备，包含它们的药物组合物以及用于制备药物的它们的使用。在一般式（I）中，R1代表-CO-CH（NH2）- SH或-CH2-CH（NH2）- SH或-CHRi1Ri2基团；R2代表氢原子，烷基，芳基烷基，芳基，烷基羰基，芳基烷基羰基，杂环烷基基团；R3代表氢原子或卤素原子或烷基，芳基，芳基烷基基团；R4代表-CHRi3Ri4基团；R5代表氢原子或-C（O）-Ri5基团；R6代表氢原子或烷基，芳基，芳基烷基基团；R7，R8代表氢原子或烷基，芳基，芳基烷基基团；X代表氢原子或-S（O）1基团中的氧原子。
• CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
  申请人：Qian Xiangping

  公开号：US20130096315A1

  公开（公告）日：2013-04-18

  Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.

  本文披露了一种通过调节一个或多个有丝分裂动力蛋白的活性来治疗细胞增殖性疾病和障碍的化合物。